Search Tag: Pfizer
2022 11 Apr
Pfizer Inc. has announced that David M. Denton will join the Company as Chief Financial Officer (CFO) and Executive Vice President effective May 2, 2022. Mr. Denton will be a member of Pfizer’s Executive Leadership Team reporting to Chairman and Chief Executive Officer, Albert Bourla. He joins Pfizer from Lowe’s Companies, Inc. where he served as CFO...Read more
2022 11 Jan
Pfizer Inc Chief Executive Albert Bourla said a redesigned COVID-19 vaccine that specifically targets the Omicron coronavirus variant is likely needed and his company could have one ready to launch by March. Bourla said Pfizer and partner BioNTech SE are working on both an Omicron-targeted vaccine version as well as a shot that would include both...Read more
2021 31 Oct
Last February, Pfizer was accused of bullying Latin American governments over COVID-19 vaccine supplies. Public Citizen, in investigating government supply contracts, found that Pfizer retains the right ‘to silence governments, throttle supply, shift risk and maximize profits in the worst public health crisis in a century.’ Their analysis included draft...Read more
2021 23 Sep
Today, 23 September, the US FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to permit a booster dose for those who are 65 years and older, who are at risk for severe disease, and whose professions bring them occupational exposure. This booster dose can be administered at least six months after completion of the primary two-dose regimen....Read more
2021 21 Sep
Given that children and adolescents can get sick with COVID-19, attending K-12 schools in-person remains a risk. According to the American Academy of Pediatrics, children accounted for 25.7% of US cases for the week of 16 September (American Academy of Pediatrics, 2021), while hospitalisations averaged 311 children/day (Centers for Disease Control...Read more
2020 18 Nov
Pfizer has completed the Phase 3 of its COVID-19 vaccine trial and is ready to seek authorisation for emergency use in the U.S. The vaccine is reported to be 95% effective. Two other vaccine candidates, those of Moderna and the Russian Gamaleya Research Institute, demonstrated 94.5% and 92% efficacy, respectively, but the trials are still...Read more
2019 26 Aug
Lions Health 2019 has offered new insights and discussions on how creativity is being embraced by the healthcare industry. Over two days, Lions Health 2019 offered new insights and fresh ideas on how creativity can be applied to improve healthcare through focussed discussion and knowledge. This year’s agenda included first-of-its-kind creativity covering...Read more
2021 25 May
POSTPONED TO 2021 DUE TO COVID-19 HEALTH CONCERNS NEW DATES 25-26 MAY, 2021 Find Arena OCT Events on Social Media Read more
2019 16 Jul
Jonathan Symonds CBE, former CFO of AstraZeneca and Novartis has been appointed to chairman at GlaxoSmithKline in the wake of the pharmaceutical company’s break-up. Symonds is currently overseeing operations at HSBC, and will replace Sir Philip Hampton, non-executive chairman at GlaxoSmithKline for the past four years. Symonds has previously...Read more
2013 17 Dec
Siemens Healthcare Diagnostics Inc. announced that it has entered into a master collaboration agreement with Pfizer Inc. to design, develop and commercialise diagnostic tests for therapeutic products across Pfizer’s pipeline. Under the agreement, Siemens will be one of Pfizer’s collaboration partners to develop and provide in vitro diagnostic tests...Read more